V Langagergaard

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study
    V Langagergaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus C, Denmark
    Aliment Pharmacol Ther 25:73-81. 2007
  2. ncbi Hodgkin's disease and birth outcome: a Danish nationwide cohort study
    V Langagergaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Allé 150, Aarhus C DK 8000, Denmark
    Br J Cancer 98:183-8. 2008
  3. ncbi Birth outcome in women with breast cancer
    V Langagergaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Allé 150, DK 8000, Aarhus C, Denmark
    Br J Cancer 94:142-6. 2006

Detail Information

Publications3

  1. ncbi Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study
    V Langagergaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus C, Denmark
    Aliment Pharmacol Ther 25:73-81. 2007
    ..Data on birth outcome after exposure to azathioprine or mercaptopurine during pregnancy is sparse...
  2. ncbi Hodgkin's disease and birth outcome: a Danish nationwide cohort study
    V Langagergaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Allé 150, Aarhus C DK 8000, Denmark
    Br J Cancer 98:183-8. 2008
    ..The overall findings are reassuring, they cannot exclude the possibility of an increased risk of congenital abnormalities for newborns of women diagnosed with HD before pregnancy...
  3. ncbi Birth outcome in women with breast cancer
    V Langagergaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Allé 150, DK 8000, Aarhus C, Denmark
    Br J Cancer 94:142-6. 2006
    ..4 (95% CI: 1.0-2.0), and the PR of low birth weight at term for boys was 2.9 (95% CI: 1.3-6.3). Overall, our results are reassuring regarding the risks of adverse birth outcome for breast cancer patients...